Circulating IL-23 Levels and Correlation with SLE Disease Activity: A Meta-Analysis
Aktuelle Rheumatologie · 01.07.2026 · 51 (04) · 229-236
DOI: 10.1055/a-2720-5838 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Aktuelle Rheumatologie, erschienen am 01.07.2026. Verfasst von Young Ho Lee und 1 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
This study aimed to evaluate the relationship between circulating interleukin-23 (IL-23) levels and systemic lupus erythematosus (SLE) as well as the correlation between plasma/serum IL-23 levels and SLE activity. The MEDLINE, EMBASE, and Web of Science databases were searched for relevant publications up to February 2025. We performed a meta-analysis comparing plasma/serum IL-23 levels between patients with SLE and healthy controls and examined correlation coefficients between circulating IL-23 levels and SLE disease activity. Sixteen studies comprising 1,125 patients with systemic lupus erythematosus (SLE) and 774 healthy controls were included. Circulating IL-23 levels were significantly elevated in the SLE group compared with controls (standardised mean difference [SMD]=1.225, 95% confidence interval [CI]=10.803–1.647, p70) and small-sample (n
Zitieren
APA
Lee, Y. H., & Song, G. G. (2026). Circulating IL-23 Levels and Correlation with SLE Disease Activity: A Meta-Analysis. Aktuelle Rheumatologie, 51(04), 229-236. https://doi.org/10.1055/a-2720-5838
Vancouver
Lee YH, Song GG. Circulating IL-23 Levels and Correlation with SLE Disease Activity: A Meta-Analysis. Aktuelle Rheumatologie. 2026;51(04):229-236. doi:10.1055/a-2720-5838
BibTeX
@article{Lee2026,
author = {Lee, Young Ho and Song, Gwan Gyu},
title = {Circulating IL-23 Levels and Correlation with SLE Disease Activity: A Meta-Analysis},
journal = {Aktuelle Rheumatologie},
year = {2026},
volume = {51},
number = {04},
pages = {229--236},
doi = {10.1055/a-2720-5838}
}
EUVIMED